| 7.7 |
30.7 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 3.2 |
9.7 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 3.1 |
12.4 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 3.0 |
12.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 2.7 |
8.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 2.5 |
12.4 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 2.2 |
17.6 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.2 |
13.0 |
GO:0002386 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 2.0 |
6.1 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.0 |
6.1 |
GO:0006174 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 1.8 |
5.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 1.7 |
66.1 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 1.7 |
5.2 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 1.7 |
8.5 |
GO:0072313 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 1.6 |
11.2 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 1.5 |
4.6 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 1.5 |
10.4 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 1.5 |
13.3 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 1.4 |
4.3 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 1.4 |
7.2 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 1.4 |
4.1 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 1.4 |
4.1 |
GO:2001301 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 1.4 |
5.4 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.3 |
4.0 |
GO:0007439 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 1.3 |
6.6 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 1.3 |
1.3 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 1.3 |
3.8 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 1.3 |
66.7 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 1.2 |
13.7 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 1.2 |
24.3 |
GO:0019614 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 1.2 |
6.1 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.2 |
3.6 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 1.2 |
3.6 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 1.2 |
25.0 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 1.2 |
4.6 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.1 |
3.2 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 1.1 |
8.5 |
GO:2000232 |
regulation of rRNA processing(GO:2000232) |
| 1.1 |
3.2 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 1.1 |
4.2 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 1.1 |
4.2 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.0 |
4.2 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 1.0 |
3.1 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 1.0 |
14.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 1.0 |
10.1 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 1.0 |
7.0 |
GO:0030242 |
pexophagy(GO:0030242) |
| 1.0 |
1.0 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 1.0 |
3.9 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 1.0 |
5.8 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.9 |
11.6 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.9 |
4.4 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.9 |
3.5 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.9 |
3.4 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.8 |
2.5 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.8 |
2.5 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.8 |
3.3 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.8 |
1.6 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.8 |
2.4 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.8 |
6.4 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.8 |
4.8 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.8 |
2.4 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.8 |
26.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.8 |
3.9 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.8 |
1.5 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.8 |
3.1 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.8 |
6.9 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.8 |
0.8 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.8 |
2.3 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.8 |
2.3 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.7 |
1.5 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.7 |
2.2 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.7 |
0.7 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.7 |
0.7 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.7 |
2.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.7 |
3.6 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.7 |
15.8 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.7 |
2.9 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.7 |
6.3 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.7 |
4.2 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.7 |
0.7 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.7 |
2.1 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.7 |
2.0 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.7 |
2.7 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.7 |
5.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.7 |
0.7 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.7 |
6.6 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.7 |
15.7 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.7 |
24.9 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.7 |
3.3 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.7 |
2.6 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.6 |
1.9 |
GO:0042710 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.6 |
1.9 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.6 |
3.8 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.6 |
0.6 |
GO:0032608 |
interferon-beta production(GO:0032608) |
| 0.6 |
0.6 |
GO:0045143 |
homologous chromosome segregation(GO:0045143) |
| 0.6 |
4.8 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.6 |
4.8 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.6 |
1.8 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.6 |
2.4 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.6 |
2.4 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.6 |
3.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.6 |
4.2 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.6 |
3.6 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.6 |
5.9 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.6 |
0.6 |
GO:0045350 |
interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.6 |
5.2 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.6 |
5.7 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.6 |
5.1 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.6 |
19.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.5 |
0.5 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.5 |
2.7 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.5 |
1.6 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.5 |
1.6 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.5 |
6.9 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.5 |
5.3 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.5 |
3.2 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.5 |
4.2 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.5 |
3.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.5 |
1.5 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.5 |
2.0 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.5 |
0.5 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.5 |
3.0 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.5 |
1.5 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.5 |
12.0 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.5 |
2.5 |
GO:0035936 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.5 |
2.0 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.5 |
2.5 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) |
| 0.5 |
1.5 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.5 |
0.5 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.5 |
3.4 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.5 |
3.4 |
GO:0045007 |
depurination(GO:0045007) |
| 0.5 |
0.5 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.5 |
8.7 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.5 |
1.4 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.5 |
2.9 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.5 |
1.9 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 0.5 |
10.4 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.5 |
3.8 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 |
0.9 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.5 |
2.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 |
0.5 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.5 |
4.1 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.5 |
1.4 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.5 |
0.9 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.5 |
1.8 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.4 |
7.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.4 |
2.7 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.4 |
1.8 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.4 |
2.6 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.4 |
2.2 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.4 |
1.3 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.4 |
1.3 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.4 |
1.3 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 |
1.7 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.4 |
2.5 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.4 |
12.5 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.4 |
2.9 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.4 |
1.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.4 |
4.9 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.4 |
3.7 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.4 |
1.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.4 |
6.9 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.4 |
1.6 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.4 |
1.2 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.4 |
1.2 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.4 |
0.4 |
GO:2000834 |
androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 0.4 |
1.2 |
GO:0003249 |
left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) cell proliferation involved in heart valve development(GO:2000793) |
| 0.4 |
5.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.4 |
1.2 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.4 |
0.4 |
GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.4 |
0.4 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.4 |
2.4 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 |
0.4 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 |
2.4 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.4 |
2.0 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.4 |
0.4 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.4 |
1.2 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.4 |
1.1 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.4 |
1.9 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.4 |
0.8 |
GO:0015811 |
sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
| 0.4 |
1.5 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.4 |
3.0 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.4 |
1.8 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.4 |
2.6 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.4 |
2.6 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.4 |
1.1 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 |
6.9 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.4 |
3.6 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.4 |
0.7 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.4 |
2.2 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.4 |
1.1 |
GO:1902725 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) negative regulation of satellite cell differentiation(GO:1902725) |
| 0.4 |
1.1 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.4 |
1.4 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.4 |
1.1 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.4 |
1.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.4 |
8.5 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.4 |
0.4 |
GO:2000426 |
negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.4 |
1.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.3 |
1.7 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.3 |
24.9 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.3 |
3.4 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 |
1.4 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.3 |
2.7 |
GO:0050428 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.3 |
3.1 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.3 |
0.7 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.3 |
1.0 |
GO:0021823 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.3 |
2.0 |
GO:1902741 |
interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.3 |
0.3 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.3 |
1.7 |
GO:0034486 |
vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
| 0.3 |
1.0 |
GO:0046398 |
UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.3 |
3.0 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.3 |
4.3 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.3 |
4.0 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 |
5.6 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.3 |
2.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
1.9 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.3 |
4.5 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 |
2.3 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.3 |
1.3 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.3 |
1.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 |
1.3 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.3 |
1.0 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.3 |
0.3 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.3 |
1.0 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.3 |
2.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
1.3 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.3 |
2.2 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.3 |
4.7 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.3 |
0.9 |
GO:0046449 |
creatinine metabolic process(GO:0046449) |
| 0.3 |
0.3 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.3 |
1.6 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.3 |
0.3 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.3 |
3.4 |
GO:0015781 |
pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.3 |
0.9 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 0.3 |
2.7 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.3 |
1.5 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.3 |
4.6 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.3 |
2.1 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.3 |
0.9 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.3 |
1.2 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.3 |
0.9 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.3 |
3.3 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.3 |
1.2 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.3 |
1.8 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.3 |
1.2 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.3 |
1.8 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.3 |
1.5 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 |
2.7 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.3 |
0.9 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.3 |
0.9 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.3 |
0.9 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.3 |
2.0 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.3 |
4.9 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
1.4 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 |
1.2 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.3 |
3.7 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.3 |
1.7 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.3 |
0.9 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.3 |
1.1 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.3 |
19.3 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.3 |
1.1 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 |
1.4 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.3 |
0.8 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 |
1.4 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.3 |
2.5 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.3 |
1.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.3 |
0.3 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.3 |
0.8 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.3 |
14.1 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.3 |
1.1 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.3 |
1.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.3 |
0.5 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.3 |
1.1 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 |
0.3 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.3 |
2.2 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.3 |
1.6 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.3 |
0.5 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) |
| 0.3 |
0.5 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.3 |
2.4 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.3 |
2.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.3 |
1.3 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.3 |
0.3 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.3 |
5.6 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.3 |
2.9 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.3 |
2.4 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.3 |
0.8 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.3 |
0.5 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.3 |
3.7 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.3 |
1.0 |
GO:0051135 |
positive regulation of NK T cell activation(GO:0051135) |
| 0.3 |
0.8 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.3 |
6.0 |
GO:0034205 |
beta-amyloid formation(GO:0034205) |
| 0.3 |
1.6 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.3 |
0.8 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.3 |
1.0 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.3 |
0.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 |
2.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.3 |
1.0 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.3 |
2.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 |
2.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 |
4.6 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.3 |
0.5 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.3 |
1.0 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.3 |
0.5 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.3 |
3.5 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.2 |
1.0 |
GO:0042797 |
tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.2 |
0.5 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.2 |
0.7 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 0.2 |
0.7 |
GO:2000870 |
regulation of progesterone secretion(GO:2000870) |
| 0.2 |
0.5 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.2 |
0.5 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.2 |
1.0 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.2 |
0.5 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.2 |
1.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 |
1.9 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.2 |
0.7 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.2 |
0.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
0.9 |
GO:2000721 |
pilomotor reflex(GO:0097195) positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 |
0.2 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.2 |
0.2 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
2.1 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.2 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.2 |
5.1 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 |
0.5 |
GO:0071499 |
cellular response to laminar fluid shear stress(GO:0071499) |
| 0.2 |
6.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.2 |
0.2 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.2 |
0.5 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.2 |
4.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
2.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
0.2 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 |
2.3 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.2 |
0.7 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.2 |
1.8 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
1.6 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
2.3 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 |
1.8 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
1.8 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.2 |
1.4 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.2 |
1.8 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
17.8 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.2 |
4.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.2 |
2.2 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.2 |
1.3 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 0.2 |
6.9 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.2 |
0.4 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 |
0.7 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) positive regulation of collateral sprouting(GO:0048672) |
| 0.2 |
0.2 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 |
2.8 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.2 |
3.6 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
1.1 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.2 |
1.3 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.2 |
5.3 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 |
3.0 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.2 |
0.8 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 |
0.6 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.2 |
0.6 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.2 |
1.3 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.2 |
0.6 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
0.4 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 |
1.7 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.2 |
2.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
0.6 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.2 |
2.3 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 |
1.4 |
GO:0042996 |
regulation of Golgi to plasma membrane protein transport(GO:0042996) |
| 0.2 |
2.3 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.2 |
1.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
0.4 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
1.2 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 |
0.4 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 |
0.6 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 |
3.6 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 |
0.6 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.2 |
1.4 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.2 |
1.0 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
0.6 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.2 |
0.6 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.2 |
1.4 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.2 |
1.6 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.2 |
5.5 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
1.0 |
GO:0010748 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.2 |
1.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
1.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 |
9.0 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.2 |
5.6 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.2 |
1.9 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.2 |
0.2 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.2 |
0.8 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.2 |
1.0 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.2 |
0.4 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.2 |
0.2 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.2 |
0.6 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 |
0.4 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.2 |
0.7 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.9 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.2 |
1.5 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.2 |
0.4 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.2 |
0.4 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.2 |
1.5 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.2 |
0.6 |
GO:0009436 |
glyoxylate catabolic process(GO:0009436) |
| 0.2 |
0.4 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.2 |
4.2 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
0.4 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
1.4 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 |
0.4 |
GO:0046075 |
dTTP metabolic process(GO:0046075) |
| 0.2 |
1.3 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 |
1.1 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
2.0 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.2 |
0.5 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.2 |
0.7 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.2 |
0.4 |
GO:0072237 |
metanephric proximal tubule development(GO:0072237) |
| 0.2 |
0.2 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.2 |
0.2 |
GO:0060526 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.2 |
0.7 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 |
0.5 |
GO:0071422 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.2 |
0.2 |
GO:0090239 |
regulation of histone H4 acetylation(GO:0090239) |
| 0.2 |
3.3 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
0.9 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 |
0.7 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) |
| 0.2 |
2.2 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.2 |
0.3 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.2 |
0.5 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.2 |
1.2 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.2 |
1.2 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
0.7 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 |
0.5 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.2 |
3.9 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 |
0.8 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.2 |
0.5 |
GO:0051311 |
meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.2 |
0.7 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.2 |
0.5 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.2 |
1.2 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.2 |
0.7 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.2 |
0.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
0.8 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.2 |
0.2 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.2 |
0.8 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 |
0.8 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.2 |
4.3 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 |
0.8 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 |
0.2 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.2 |
0.5 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.2 |
2.3 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.2 |
1.5 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.2 |
2.1 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.2 |
0.5 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 |
0.5 |
GO:0042489 |
negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.2 |
1.0 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 |
1.4 |
GO:0043967 |
histone H4 acetylation(GO:0043967) |
| 0.2 |
0.3 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.2 |
0.6 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
5.2 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
0.8 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.2 |
0.5 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.2 |
0.5 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.2 |
0.2 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) |
| 0.2 |
6.4 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.2 |
5.9 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
0.5 |
GO:0061028 |
establishment of endothelial barrier(GO:0061028) |
| 0.2 |
4.2 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.2 |
0.8 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
| 0.2 |
2.9 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
2.5 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.1 |
0.7 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
2.5 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.3 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 |
0.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.4 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
0.1 |
GO:0072711 |
cellular response to hydroxyurea(GO:0072711) |
| 0.1 |
1.2 |
GO:0030307 |
positive regulation of cell growth(GO:0030307) |
| 0.1 |
0.6 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 |
14.8 |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.1 |
0.6 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
1.3 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.1 |
0.1 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 |
3.1 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
1.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
0.3 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 |
0.3 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
2.6 |
GO:0097242 |
beta-amyloid clearance(GO:0097242) |
| 0.1 |
0.1 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.1 |
0.4 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
0.5 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.1 |
0.3 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.7 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.1 |
9.4 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.7 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 |
0.4 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.1 |
0.4 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
2.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
0.4 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
0.3 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
1.8 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
2.5 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.5 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.9 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
1.8 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.8 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.5 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
1.0 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
2.6 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.1 |
0.5 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.6 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
0.6 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.8 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.1 |
2.8 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
0.4 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 |
1.0 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
1.0 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 |
0.8 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.3 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
2.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.2 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
0.2 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
0.4 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.1 |
1.0 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.6 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.1 |
0.2 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 |
1.7 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.7 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
0.2 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.1 |
1.1 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
1.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
1.2 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.1 |
0.6 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.1 |
1.2 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.8 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
0.1 |
GO:0035087 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.5 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.1 |
1.4 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.1 |
0.8 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 |
0.7 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.1 |
1.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.5 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.1 |
0.8 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.1 |
0.2 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.4 |
GO:0090264 |
immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
| 0.1 |
0.3 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.1 |
0.5 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 |
0.1 |
GO:0043144 |
snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.1 |
0.5 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.8 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 |
0.9 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.3 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.1 |
0.2 |
GO:2000854 |
positive regulation of corticosterone secretion(GO:2000854) |
| 0.1 |
0.7 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.5 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 |
0.1 |
GO:0071888 |
macrophage apoptotic process(GO:0071888) |
| 0.1 |
1.9 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
0.8 |
GO:0002634 |
regulation of germinal center formation(GO:0002634) |
| 0.1 |
0.9 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
2.0 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.3 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
0.3 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.3 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.1 |
0.2 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 |
0.1 |
GO:2000143 |
negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.1 |
0.2 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.1 |
0.5 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 |
0.3 |
GO:0014909 |
smooth muscle cell migration(GO:0014909) |
| 0.1 |
0.7 |
GO:0060326 |
cell chemotaxis(GO:0060326) |
| 0.1 |
0.2 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.1 |
1.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.6 |
GO:2000501 |
regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 |
0.1 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.1 |
0.1 |
GO:0043247 |
telomere maintenance in response to DNA damage(GO:0043247) |
| 0.1 |
0.4 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 |
0.4 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.1 |
0.9 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.5 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
1.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.2 |
GO:0021545 |
cranial nerve development(GO:0021545) |
| 0.1 |
1.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
1.2 |
GO:0060260 |
regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
| 0.1 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.6 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.4 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
6.2 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.1 |
0.7 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.4 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.1 |
2.1 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.3 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 |
1.0 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.1 |
1.3 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 |
20.4 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.1 |
1.6 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.4 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.1 |
0.8 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 |
0.5 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.6 |
GO:1904995 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
1.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.3 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.4 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
0.3 |
GO:2000786 |
positive regulation of vacuole organization(GO:0044090) positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
0.1 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.1 |
1.6 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.7 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 |
0.2 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.1 |
0.1 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.1 |
0.4 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
0.2 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.1 |
0.4 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
7.9 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.1 |
0.3 |
GO:0039656 |
modulation by virus of host transcription(GO:0019056) modulation by virus of host gene expression(GO:0039656) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.1 |
0.2 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.7 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.7 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
0.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.1 |
0.8 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
13.1 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.1 |
0.8 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 |
0.1 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 |
0.3 |
GO:2000269 |
fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 |
0.5 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 |
1.2 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.4 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.1 |
GO:1904994 |
regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
| 0.1 |
0.4 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.1 |
0.2 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.1 |
0.4 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.1 |
1.3 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
0.1 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.1 |
2.2 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
3.1 |
GO:0042407 |
inner mitochondrial membrane organization(GO:0007007) cristae formation(GO:0042407) |
| 0.1 |
0.3 |
GO:0043574 |
peroxisomal transport(GO:0043574) |
| 0.1 |
0.3 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.1 |
0.9 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.1 |
0.6 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.9 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.5 |
GO:0002371 |
dendritic cell cytokine production(GO:0002371) |
| 0.1 |
0.8 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 |
1.3 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.1 |
4.3 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.3 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.1 |
0.3 |
GO:0003157 |
endocardium development(GO:0003157) |
| 0.1 |
0.3 |
GO:1903364 |
positive regulation of cellular protein catabolic process(GO:1903364) |
| 0.1 |
0.8 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
0.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.4 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.3 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.3 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.1 |
0.5 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
1.0 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
2.7 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.1 |
0.3 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.1 |
1.0 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.8 |
GO:0048003 |
antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.2 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.1 |
0.2 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
1.9 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
0.2 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 |
0.2 |
GO:1903936 |
response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.1 |
0.5 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 |
0.2 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.1 |
0.8 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.1 |
0.4 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 |
0.5 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.2 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.1 |
0.2 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 |
0.3 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 |
0.1 |
GO:2000583 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.1 |
0.1 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.1 |
0.4 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
0.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.2 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.1 |
0.5 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.4 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.3 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 |
1.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.5 |
GO:1904936 |
substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 |
0.4 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.3 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.1 |
2.7 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.1 |
1.1 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.1 |
0.2 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 |
0.5 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.2 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.1 |
0.2 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
1.0 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
1.6 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
1.0 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
0.1 |
GO:0060998 |
regulation of dendritic spine development(GO:0060998) |
| 0.1 |
2.9 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
0.5 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.1 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.1 |
0.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.2 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
1.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.6 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
3.1 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.1 |
2.1 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
0.1 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.1 |
0.3 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.1 |
0.3 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.1 |
2.2 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
1.0 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.1 |
0.3 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 |
1.0 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.5 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.1 |
0.5 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.2 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
1.3 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.1 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.3 |
GO:2001293 |
malonyl-CoA metabolic process(GO:2001293) |
| 0.1 |
0.3 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.1 |
0.6 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.1 |
1.5 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.4 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.1 |
0.3 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.3 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
0.3 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) positive regulation of fatty acid metabolic process(GO:0045923) |
| 0.1 |
1.6 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.6 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.1 |
0.2 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.8 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
0.5 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.3 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.3 |
GO:0045954 |
positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.1 |
1.7 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.3 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 |
0.6 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.3 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.6 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.7 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.1 |
1.4 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.4 |
GO:1904209 |
regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.1 |
0.1 |
GO:0035587 |
purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.2 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.1 |
0.1 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 |
0.1 |
GO:1901624 |
negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 |
0.2 |
GO:0035264 |
multicellular organism growth(GO:0035264) |
| 0.1 |
0.1 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
0.5 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.3 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.3 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.3 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.1 |
0.4 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
2.6 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.1 |
GO:2000374 |
regulation of oxygen metabolic process(GO:2000374) |
| 0.1 |
0.2 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 |
0.5 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
0.2 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.1 |
1.3 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
0.2 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.1 |
0.4 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.1 |
0.2 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
0.1 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 |
1.1 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.1 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.1 |
4.8 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.1 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.1 |
0.1 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.2 |
GO:0043324 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 |
0.5 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.1 |
0.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.3 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
1.7 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.2 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
1.9 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.9 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.7 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.1 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.1 |
0.6 |
GO:0043578 |
nuclear matrix organization(GO:0043578) |
| 0.1 |
0.2 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 |
0.6 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.1 |
0.3 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
| 0.1 |
2.8 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.2 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.1 |
0.2 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 |
0.1 |
GO:1904044 |
response to aldosterone(GO:1904044) |
| 0.1 |
0.2 |
GO:0002003 |
angiotensin maturation(GO:0002003) |
| 0.1 |
0.6 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.4 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.1 |
0.5 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.1 |
0.4 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 |
0.3 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.1 |
GO:0010710 |
regulation of collagen catabolic process(GO:0010710) |
| 0.1 |
0.1 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.1 |
3.8 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.3 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
1.1 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.2 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.0 |
0.1 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.0 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
1.5 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 |
0.1 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.1 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.0 |
0.1 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.0 |
0.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.7 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.4 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.4 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.0 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.2 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.1 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.0 |
0.2 |
GO:0009445 |
putrescine metabolic process(GO:0009445) |
| 0.0 |
0.1 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.1 |
GO:0051181 |
cofactor transport(GO:0051181) |
| 0.0 |
0.5 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.7 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
1.9 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.1 |
GO:0019048 |
modulation by virus of host morphology or physiology(GO:0019048) |
| 0.0 |
0.2 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.4 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.7 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.0 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
0.2 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.3 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 |
0.7 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.0 |
0.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.0 |
0.4 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.0 |
1.3 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.0 |
0.5 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
0.2 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.0 |
0.2 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.0 |
0.2 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.6 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.0 |
0.3 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.0 |
0.3 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.1 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.0 |
0.4 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.3 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.1 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.0 |
0.1 |
GO:0030852 |
regulation of granulocyte differentiation(GO:0030852) |
| 0.0 |
1.4 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.2 |
GO:0010935 |
regulation of macrophage cytokine production(GO:0010935) |
| 0.0 |
0.1 |
GO:0003223 |
ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.0 |
0.2 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.3 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.2 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.0 |
0.2 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.0 |
0.6 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.0 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.0 |
0.6 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.0 |
0.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.0 |
2.9 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.2 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.0 |
0.3 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.0 |
0.2 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.0 |
1.0 |
GO:1990090 |
cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 |
0.0 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.0 |
0.1 |
GO:0046639 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of alpha-beta T cell differentiation(GO:0046639) |
| 0.0 |
0.1 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.0 |
2.3 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.1 |
GO:0003340 |
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.0 |
1.7 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.0 |
1.1 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.1 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.3 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.0 |
0.2 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.7 |
GO:0002381 |
immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
| 0.0 |
0.2 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.0 |
0.1 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 |
0.2 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 |
6.1 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.0 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 |
0.3 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 |
1.4 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.2 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.0 |
0.3 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.0 |
0.0 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.0 |
0.7 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.3 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.0 |
0.1 |
GO:1905097 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.0 |
0.5 |
GO:2001046 |
positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.0 |
0.2 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.0 |
0.5 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.2 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.0 |
0.1 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 |
0.1 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.1 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.0 |
0.1 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.0 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.0 |
0.1 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 0.0 |
0.8 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.0 |
GO:0097068 |
response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.0 |
0.1 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.0 |
0.3 |
GO:0060021 |
palate development(GO:0060021) |
| 0.0 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.0 |
0.2 |
GO:0099515 |
vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.0 |
0.2 |
GO:1990441 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.0 |
0.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.0 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.4 |
GO:0071380 |
cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.0 |
0.0 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 |
0.4 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.0 |
0.1 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.0 |
0.1 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.0 |
0.5 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.0 |
0.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.1 |
GO:1902583 |
multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.2 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.0 |
0.2 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.8 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 |
0.2 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.0 |
0.5 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.0 |
0.2 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.1 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.0 |
1.2 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.4 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 |
0.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.1 |
GO:0007618 |
mating(GO:0007618) |
| 0.0 |
0.2 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.0 |
0.9 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.1 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.0 |
0.1 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.2 |
GO:0031269 |
pseudopodium assembly(GO:0031269) |
| 0.0 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.1 |
GO:0070424 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.0 |
0.7 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
0.1 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.0 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.0 |
0.1 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.4 |
GO:0015669 |
gas transport(GO:0015669) |
| 0.0 |
0.7 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.1 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.1 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 |
0.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.2 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.0 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 |
0.4 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.1 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.0 |
0.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.0 |
0.0 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.0 |
0.1 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
0.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.5 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.0 |
0.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
1.0 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.0 |
0.0 |
GO:0014744 |
positive regulation of muscle adaptation(GO:0014744) |
| 0.0 |
0.4 |
GO:0007595 |
lactation(GO:0007595) |
| 0.0 |
1.4 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.0 |
0.9 |
GO:0009583 |
detection of light stimulus(GO:0009583) |
| 0.0 |
0.2 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.1 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.0 |
GO:0098910 |
regulation of atrial cardiac muscle cell action potential(GO:0098910) |
| 0.0 |
0.1 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
0.2 |
GO:0046785 |
microtubule polymerization(GO:0046785) |
| 0.0 |
0.1 |
GO:0001971 |
negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.0 |
0.2 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.3 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.0 |
0.3 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.0 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.1 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.0 |
0.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.1 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.0 |
0.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.2 |
GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.0 |
0.3 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.0 |
0.1 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 |
0.2 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.1 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.1 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.0 |
0.1 |
GO:0097049 |
motor neuron apoptotic process(GO:0097049) |
| 0.0 |
0.2 |
GO:0030890 |
positive regulation of B cell proliferation(GO:0030890) |
| 0.0 |
0.1 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.0 |
0.1 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 0.0 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.1 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.0 |
0.0 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 |
0.2 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.2 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 |
0.0 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.0 |
0.1 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.1 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.7 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.0 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.0 |
0.1 |
GO:0006067 |
ethanol metabolic process(GO:0006067) |
| 0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.1 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.0 |
0.0 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.0 |
0.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.1 |
GO:0035926 |
interleukin-21 production(GO:0032625) chemokine (C-C motif) ligand 2 secretion(GO:0035926) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.0 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.1 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.1 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.0 |
GO:0014870 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) |
| 0.0 |
0.0 |
GO:0002351 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.0 |
0.1 |
GO:0050773 |
regulation of dendrite development(GO:0050773) |
| 0.0 |
0.2 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.2 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
0.0 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 |
0.0 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.0 |
0.0 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.0 |
0.0 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.0 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.0 |
0.1 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.0 |
0.0 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.0 |
0.0 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.3 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.0 |
0.2 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
